Mineralys Therapeutics Inc. Gains 42.21%

Mon, Mar 10, 2025 at 08:11 PM
Mineralys Therapeutics Inc. Gains 42.21%

Mineralys Therapeutics Inc. (MLYS:NASDAQ) rocketted at $14.96, a gain of 42.2%. On Mon, Mar 10, 2025, MLYS:NASDAQ hit a New 2-Week High of $14.96. The stock appeared on our News Catalysts scanner on Mon, Mar 10, 2025 at 06:41 PM in the 'PUBLIC OFFERING' category. From Mon, Feb 24, 2025, the stock recorded 60.00% Up Days and 54.55% Green Days

About Mineralys Therapeutics Inc. (MLYS:NASDAQ)

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.